EDGAR Filing Documents for 0001193125-16-463896

Form 8-K - Current report:

SEC Accession No. 0001193125-16-463896

Filing Date

2016-02-16

Accepted

2016-02-16 07:35:30

Documents

Period of Report

2016-02-15

Items

Item 2.02: Results of Operations and Financial Condition
Item 4.02: Non-Reliance on Previously Issued Financial Statements or a Related Audit Report or Completed Interim Review
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	d114400d8k.htm	8-K	51099
2	EX-99.1	d114400dex991.htm	EX-99.1	174406
3	GRAPHIC	g114400page7.jpg	GRAPHIC	3847
	Complete submission text file	0001193125-16-463896.txt		232368

Mailing Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195

Business Address 1901 NORTH ROSELLE ROAD, SUITE 700 SCHAUMBURG IL 60195 847-908-1604

Sagent Pharmaceuticals, Inc. (Filer) CIK: 0001369786 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE
Type: 8-K | Act: 34 | File No.: 001-35144 | Film No.: 161422981
SIC: 2834 Pharmaceutical Preparations